Literature DB >> 1425864

Doctors' perception of pertinent information. Results of a survey of a random sample of French general practitioners. GEP (Groupe d'Etude de la Prescription).

G Figon1, J P Boissel, J C Peyrieux.   

Abstract

The results of a survey aimed at investigating which tools prescribers have at hand to help them to identify pertinent information from a background of "noise" are reported. A questionnaire was sent to 250 general practitioners randomly selected from a list of those practicing in the Rhône-Alpes region in France, of whom 117 (46.8%) replied. The questionnaire consisted of three sections, the first explored how they dealt with intermediate and clinical outcomes in trials, the second presented a series of statements to identify what would make them prescribe a new drug, and the third looked at their knowledge of therapy assessment methodology. It was found that most general practitioners had not been trained to identify the most salient information for selecting the best treatment. This implies that both medical students and qualified doctors should be taught to recognise pertinent information.

Entities:  

Mesh:

Year:  1992        PMID: 1425864     DOI: 10.1007/bf01740654

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Do prescribers know the results of key clinical trials? GEP (Groupe d'étude de la Prescription).

Authors:  S Reveilleau; J P Boissel; Y Alamercery
Journal:  Fundam Clin Pharmacol       Date:  1991       Impact factor: 2.748

Review 2.  Impact of randomized clinical trials on medical practices.

Authors:  J P Boissel
Journal:  Control Clin Trials       Date:  1989-12

3.  The impact of controlled trials on the practice of medicine.

Authors:  T C Chalmers
Journal:  Mt Sinai J Med       Date:  1974 Nov-Dec

4.  Educational antibiotic advertising campaign.

Authors:  K Harvey; M Hemming; N Naismith; R Moulds
Journal:  Med J Aust       Date:  1983-11-26       Impact factor: 7.738

5.  Use of cimetidine; parallels and discrepancies between the views of drug regulatory agencies and practicing physicians.

Authors:  F M Haayer; G T van der Werf; N F Wieringa; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Impact of the Coronary Drug Project findings on clinical practice.

Authors:  L Friedman; N K Wenger; G L Knatterud
Journal:  Control Clin Trials       Date:  1983-12

7.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

8.  Funding for clinical trials.

Authors:  C L Meinert
Journal:  Control Clin Trials       Date:  1982-09

9.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

Review 10.  Evaluating the benefit of clinical trials to future patients.

Authors:  B S Hawkins
Journal:  Control Clin Trials       Date:  1984-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.